Gender-Affirming Care, Drug Pricing Reform, and 340B Updates with Paige Twenter

Advertisement

This episode features Paige Twenter, Assistant Editor at Becker’s Hospital Review, as she discusses key healthcare policy developments including restrictions on gender-affirming care, federal pressure on pharmaceutical companies to lower U.S. drug prices, and major changes to the 340B drug pricing program.

Advertisement

Next Up in Becker's Healthcare Podcast Episodes

Advertisement

Comments are closed.